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Magnetic resonance imaging (MRI) is one of the most powerful diagnostic modalities for 
imaging of the brain, cartilage, heart, blood vessels and tumors with superb spatial resolution and 
soft tissue contrast. However, the commonly used small molecular contrast agents, for example 
gadolinium complexes, are highly toxic in the free ionic forms and suffer from low MRI 
sensitivity. Alternatively, nanostructures formed by self-assembling molecules can be employed 
as carriers for MRI agents, which significantly improves imaging contrast and relatively reduces 
associated cytotoxicity. Amphiphilic peptides (APs) are rationally designed small molecule 
peptide conjugates possessing a great potential for self-assembly in aqueous solution. Depending 
on the design rationale and assembly environment, various one-dimensional morphologies with 
different physical properties can be obtained upon self-assembly of APs. The inherent 
biocompatibility of peptidic molecules, combined with their possible bioactivity, renders APs a 
versatile platform for MRI. Chemical Exchange Saturation Transfer (CEST) is an emerging MRI 
contrast mechanism, which utilizes special MRI pulses sequence to selectively detect 
exchangeable protons on each probe at their unique chemical shift, translating them into a 
frequency-specific molecular imaging agents. In this study, we conjugated Pemetrexed (under the 
trade name Alimta), the FDA-approved anticancer drug, onto the short peptide sequence, to create 
an amphiphilic peptide (PemFE) that could form nanofibers hydrogel. Compared with contrast 
agents labelled with metal chelates, pemetrexed itself has inherent CEST MRI signal at 5.2 ppm 
frequency offset from the resonance of water. This platform offers us a “label free” method to 
trace the delivery and distribution of PemFE nanofiber hydrogel in mouse glioma model. Our in 
vivo study demonstrated that the injected PemFE hydrogel in mouse glioma tumors could be 
detected using CEST MRI for up to 4 days post-implantation. 
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Chapter 1: Introduction 
 
1.1 Basic Principles of Magnetic Resonance Imaging (MRI) contrast agents 
1.1.1 T1 and T2 weighted MRI 
As illustrated in Figure 1a, upon exposure to an external magnetic field (B0), a greater 
proportion of protons will prefer to align parallel to the magnetic field (lower energy state), while 
the remainder aligns antiparallel (higher energy state). Therefore, a net magnetization (Mz) is 
produced along the direction of magnetic field (z-axis), and protons spin around the z-axis at a 
precession rate named the Larmor frequency (ω0). During this period, protons precess separately 
(out of phase). When an RF pulse is applied to the nuclei with the same precession frequency, 
some protons in the lower energy state are flipped to the higher state by absorbing the RF energy 
(Figure 1b). Furthermore, the protons become synchronized and precess together (in phase). 
































Figure 1. The principles of magnetic resonance imaging. a) Protons align either parallel 
(majority) or antiparallel (minority) and precess under external magnetic field B0. b) Upon the 
introduction of RF pulses, protons are excited, with relaxation occurring following removal of the 
RF pulses. Graphical representation of c) T1 relaxation (eqn (1)) and d) T2 relaxation (eqn (2))1.  
After removal of the RF pulse, the protons relax to their equilibrium state via two 
relaxation pathways: longitudinal relaxation (T1 relaxation) and transverse relaxation (T2 
relaxation). In T1 relaxation, antiparallel protons jump back to the parallel state and give up 
energy to molecules in the surrounding environment (lattice), so that T1 relaxation is known as 
spin-lattice relaxation. The recovery of Mz is described in equation below (1), where the T1 
relaxation time is defined as the time taken to recover 63% of the original longitudinal 
magnetization. The T1 relaxation rate, R1, is given by the reciprocal of T1 (1/T1), which is a 
function of r1 (T1 relaxivity), an intrinsic property of T1 contrast agents, and contrast agent 
concentration (see equation (2)).  The ideal T1 contrast agents should be able to effectively 
shorten the T1 relaxation time at low concentration. In terms of T2 relaxation (spin-spin 
relaxation), protons that are in phase begin to dephase, with the transverse magnetization (Mxy) 
decaying as a result. This decay process follows equation (3), where T2 refers to the time taken to 
decay to 37% of the original Mxy value. T2 relaxivity (r2), an intrinsic property of T2* contrast 
agents, affects the T2 relaxation rate, R2, as described in equation (4). Generally, spins decay 
faster than T2 due to the magnetic field inhomogeneity generated by T2 contrast agents. After 
taking this inhomogeneity into consideration, the effective relaxation time (T2*) is given by 
equation (5), where γ is the gyromagnetic ratio and ΔBi is the difference in the local magnetic 






1.1.2 Chemical Exchange Saturation Transfer 
The contrast of chemical exchange saturation transfer (CEST) is generated through 
chemical exchange between solute and solvent, and can be proton or small molecule exchange 
(Figure 2e–i)2. The simplest model used to describe this process is the two-pool model, shown in 
Figure 23. The exchangeable solute protons are selectively saturated by radiofrequency (RF) 
irradiation, and the saturated solute protons are subsequently transferred to bulk water protons by 
the exchange process, so that the signal of bulk water is attenuated. Since the water pool 
(concentration of about 110 M) is much larger than the solute pool (concentration in micromolar 
to millimolar range), each presaturated solute proton will be replaced by a non-saturated bulk 
water proton, and therefore another exchange occurs. With a fast exchange rate and long 




Figure 2. CEST principle. (a) Exchangeable solute protons are selectively saturated at a specific 
resonance frequency (RF) (8.25 ppm for amide protons), and the saturation is subsequently 
transferred to water (4.75 ppm). Non-saturated protons (black) are replaced by saturated solute 
protons (blue), and the process will be repeated to generate a discernable effect on the water 
signal intensity. (b) The saturation transfer causes water signal attenuation after tsat. (c) Z 
spectrum (or CEST spectrum, MT spectrum). When RF irradiates at 4.75 ppm, the water signal 
disappears because of direct saturation (DS), and the frequency is set to 0 ppm in Z spectrum. 
After a period of RF saturation (tsat), CEST effect becomes obvious, and the frequency of solute 
protons (amide protons) is 8.25–4.75 = 3.5 ppm. (d) MTRasym spectrum: asymmetry analysis of Z 
spectrum to remove DS effect. Various exchange pathways: (e) proton exchange, (f) molecule 
exchange, (g) proton and molecule exchange, (h) compartment exchange, and (i) molecule-
mediated compartment exchange1. 
1.2 Self-assemblies for MRI 
Magnetic resonance imaging (MRI), developed on the principle of nuclear magnetic 
resonance (NMR), is one of the most powerful tools extensively used for noninvasive molecular 
and cellular imaging4. With superb spatial resolution and tissue contrast, MRI provides anatomic 
images of soft tissues and is considered as one of the most important diagnostic modalities for 
imaging of the brain5, cartilage, heart, blood vessels and for tumor detection6. Unlike other 
imaging platforms, such as computerized axial tomography (CAT), positron emission 
tomography (PET) and single-photon-emission computed tomography (SPECT), MRI techniques 
do not require the use of radioactive agents and ionizing radiation. Although MRI itself is able to 
provide detailed images of soft tissues, its intrinsic low sensitivity makes it hard to differentiate 
normal tissues from lesions. The introduction of supplements, called contrast agents, can enhance 
the contrast effect at regions of interest by accelerating magnetic relaxation7, 8. These MRI 
contrast agents can be divided into three groups based on the mechanism by which contrast is 
generated. T1 agents provide positive contrast by shortening the longitudinal relaxation time of 
surrounding water molecules, whereas T2 agents shorten the transverse relaxation time of water 
protons. The third group relies on chemical exchange saturation transfer (CEST) and represents a 
relatively new approach to enhance MRI contrast. CEST agents exchange their presaturated 
exchangeable protons with those of bulk water, with the MRI contrast capable of being switched 
“on” and “off” by irradiation with radiofrequency (RF) pulses. 
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Among the various contrast agents, nanoparticle-based contrast agents (especially 
nanoparticles with diameters of 1–100 nm) have become extremely attractive due to their unique 
features. Firstly, nanoparticles can be loaded with up to hundreds of thousands of imaging 
moieties per structure, providing superb signal amplification that enables good imaging contrast 
at a low dose of contrast agent, and reduces the potential for any cytotoxicity associated with the 
contrast agent9. For example, a 150 nm dendrimer nanocluster possesses a loading capacity of 
~300,000 gadolinium ions, giving a r1 relaxivity value of 12.3 mM-1sec-1 per gadolinium ion and 
3,600,000 mM-1sec-1 per particle (1.41 T, 40 °C)10, while the r1 relaxivity value of small 
gadolinium chelates is only 3.5 mM-1sec-1. Secondly, compared to bulk counterparts, 
nanoparticles possess a relatively large surface area that offers improved reactivity and an ability 
to be tailored with additional surface moieties to either improve targeting11 or introduce additional 
functionality (such as therapeutic features12 or fluorescence13). Multimodal MRI contrast agents 
are even more prevalent since they can reveal several properties at the same site by applying a 
single contrast agent. Thirdly, nanoparticles tend to accumulate at tumor sites through the 
enhanced permeability and retention (EPR) effect14, thereby rendering a higher signal-to-noise 
ratio in tumors15.  
Researchers have developed various types of nanoparticle-based MRI contrast agents of 
T1, T2 and CEST modalities to fulfill different purposes. Among them, T1 nanoparticle-based 
contrast agents have proven the most popular due to the positive contrast provided. Gadolinium 
(GdIII) complexes like Gd-DTPA are widely used to detect the breakage of the blood brain barrier 
(BBB) and characterize changes in vascularity16. However, GdIII chelates have a short circulation 
time and the relaxivity exhibited is relatively low, requiring a large dose of ion chelates to reach a 
useful detection level. Moreover, the non-biocompatible gadolinium has the potential to introduce 
toxicity into cells upon dechelation from its complexes. Alternatively, nanostructures (like 
dendrimers17, liposomes18, quantum dots19, mesoporous silica20 and carbon nanotubes21) can be 
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employed as carriers for GdIII chelates, which significantly improves relaxivity, and the 
nanoparticle surface can be facilely modified with additional functional groups to create 
multimodal contrast agents. As members of soft nanoparticles, supramolecular self-assemblies 
based MRI contrast agents have quickly drawn researchers’ attention since their first introduction 
by Stupp and Meade22, where self-assembling peptide amphiphiles (PAs) were conjugated with 
macrocyclic GdIII chelates to furnish peptide-amphiphile based T1 MRI contrast agents (PACAs). 
Nanostructures self-assembled from PAs can emulate extracellular matrices, a biomimetic 
strategy widely applied in the field of regenerative medicine23. Depending on the design rationale 
and assembly environment, various one-dimensional morphologies with different physical 
properties can be obtained upon self-assembly of PAs, which renders PACAs a versatile platform 
for imaging purposes24. Most importantly, it is well known that the relaxivity of contrast agents 
will be enhanced by conjugation to proteins and polymers with large molecular weight, or by 
preparation of micellar structures25. Similarly, the structure of self-assembled PAs allows the 
increase in rotational correlation time (τr) that subsequently enhances relaxivity. Bull et al. 
reported the relaxivity difference that arose from the varying morphology of two self-assembled 
PAs (Figure 3a,b), where the relaxivity of nanofibers was 14.7 mM-1sec-1, while the relaxivity of 
spherical micelles was 22.8 mM-1sec-1 before cross linking (pH = 7.41)26, both of nanostructure 
dramatically improved T1 sensitivity compared with small molecular GdIII chelates (r1 ~ 3.5 mM-
1sec-1). 
MRI has also been used to image self-assembled hydrogel in Bull’s work. Bull et al. 
fabricated three molecules (1, 2, 3) with similar sequences (Figure 3c,d), with PA 1 able to form 
self-supporting hydrogels, while PACAs 2 and 3 possessed Gd-DOTA positioned at different 
distances from the hydrophobic alkyl tails. Both PACAs self-assembled into nanofibers at pH 
greater than 7.0, though cannot form hydrogels by themselves22. Upon mixing PACA 2 or 3 with 
filler PA 1, a homogeneous hydrogel was formed that allowed MR images to be obtained. From 
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the MR images of these phantom gels, the mixture of PACA 3 and PA 1 exhibited the greatest 
contrast, implying that positioning GdIII chelates closer to the hydrophobic end of PAs would 
result in higher relaxivity. The postulated reason behind this was due to the decreased internal 
flexibility and increased steric hindrance of GdIII chelates that occurs upon self-assembly. Since 
the highest contrast was generated with PACA 3, it was further mixed with various epitope-
bearing PAs (such as the IKVAV or YIGSR epitopes for neuronal stem cell differentiation, and 
the RGD epitope for cell adhesion) to form hydrogels (doping with an equal amount of 3). The T1 
values of each mixed hydrogel were found to be similar, proving the ubiquitous ability to use 
PACAs with various PA gels. 
 
 
Figure 3. Self-assembled peptide amphiphile nanofibers conjugated with Gd-based magnetic 
moieties. a) AFM image of nanofibers. b) Atomic force microscopy (AFM) image of 
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nanospheres. c) Molecular design of 1, 2, 3. d) MR images of phantom gels formed from (1) the 
control PA of 1, (2) a mixture of 1 and 2, (3) a mixture of 1 and 3, and (4) Gd-DTPA. The 
mixture of 1 and 3 demonstrated the highest contrast due to the increase in τr of GdIII chelates1.  
What’s more, the feasibility of employing supramolecular dual-modality nanoprobes 
(self-assembly of amphiphilic peptide conjugates containing the fluorophore 5-FAM and Gd-
DOTA) as contrast agents for MR and fluorescence imaging was assessed by Cui and co-workers 
(Figure 4)27. The live-cell fluorescence imaging of two self-assembled nanoprobes (one with 
single hydrocarbon tail, and the other with two hydrocarbon tails) was studied in KB-3-1 human 
cervical cells to evaluate cell viability of PACAs. The dual-tailed PACA 2 (50 µM) showed 25-
fold higher cellular uptake than PACA 1 (200 µM), which was due to membrane insertion 
through the two hydrophobic alkyl chains. Before self-assembly, the relaxivity, r1, of PACA 1 
and PACA 2 were 4.3 mM-1sec-1 and 4.2 mM-1sec-1 (pH = 7.4, room temperature), respectively, 
which were similar to the relaxivity of small molecular Gd-DOTA contrast agents (3.5–4.8 mM-
1sec-1)28. However, upon self-assembly, the nanospheres formed by PACA 1 and PACA 2 had 
relaxivities of 7.8 mM-1sec-1 and 14.3 mM-1sec-1 that were higher than the monomeric forms. The 
higher relaxivity of self-assembled PACA 2 stems from the denser packing of PACA 2 in its self-
assembled state, which led to a higher aggregation number of molecules and effective molar mass 
than self-assembled PACA 1. 
 
Figure 4. Dual-modal supramolecular nanoprobes. a) Rational design of supramolecular dual-
modality nanoprobes, composed of a hydrophobic domain to promote self-assembly, a 
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fluorophore for optical imaging, a GdIII chelator for MR contrast, and a hydrophilic headgroup. 
b) Chemical structures of PACA 1 and PACA 2. Fluorescence images of KB-3-1 cells after 
incubation (2h) with c) PACA1 (200 µM) and d) PACA2 (50 µM). Scale bars were 20 µm.  e)-f) 
The plots of 1/T1 versus concentration for [Gd (III)]-1 and [Gd (III)]-2. Slopes as r11.  
As we described above, self-assembling PAs have the propensity to enhance T1 relaxivity, 
and one advantage associated with fibrous PA structures is their potential for biodegradation into 
natural building blocks, so that it is of importance to track the fate of biomaterials after implanted 
in vivo29. There are, however, limited studies that shed light on the degradation process in vivo. 
By incorporating MRI modality to image PACAs, we could rationalize using PACAs to enhance 
MRI contrast, and possibly allow us to track the fate of PACAs in vivo, thus laying a critical 
foundation for future development as therapies30. Stupp, Meade and co-workers have reported on 
the in vivo biomaterial localization with Gd(HPN3DO3A) labelled peptide nanofibers (Figure 5). 
These PAs were designed to have one chelate next to the C-terminal (PA1 and PA2), three 
chelates at the C-terminal end (PA3), or one chelate relatively far away from the C-terminus 
(PA4)29. Small-angle X-ray scattering (SAXS) experiments revealed that the bulky Gd 
(HPN3DO3A) conjugated to the outermost residue of the PAs exhibited β-sheet character and 
retained high-aspect-ratio structures. The in vivo degradation was evaluated with the mixture 
(gels) of PA (1 or 3) and filler C16V3A3E3-NH2, of which the PA1 gel produced positive contrast 
in T1-weighted MRI and PA3 gel produced negative contrast. Subsequent ICP-MS analysis was 
conducted to measure GdIII retention. The result showed that 62 ± 8% of PA1 and 54 ± 9% of 
PA3 remained in the mouse leg after 4 days, and the similar T1 relaxation time at day 0 and day 4 
indicated the PA concentration did not change significantly, verifying that the approach of using 
MRI to track the fate of biomaterials is practicable.  
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Figure 5. In vivo biomaterial localization with Gd-labeled peptide nanofibers. a) Schematic 
illustration of the ‘clicking’ of Gd(HPN3DO3A) to the alkyne peptoid. Chemical structure of the 
self-assembling MRI contrast agents PA1–PA4. b) Cartoon of self-assembled nanofibers of PA1. 
In vivo evaluation of PA1 and PA3: c) 4 uL of PA gels were injected into each of six wild-type 
mice (injection point indicated by white arrows), and anatomical scan of mouse legs was 
performed immediately upon injection (top row) and after 4 days (bottom row). PA1 produced 
positive contrast in T1 weighted MRI, while PA3 produced negative contrast in T2 weighted MRI. 
d) Average T1 times from the region of interest and the background measured several millimeters 




Chapter 2: CEST MRI traceable self-assembling drug-peptide 
nanofiber 
Over past decades, we witnessed remarkable development of drug delivery strategies. 
There are, however, remaining challenges that limit the efficacy of chemotherapeutic drugs in 
cancer treatment. Due to non-selective accumulation in healthy organs, such as kidney and liver 
spleen, only a small amount of drug arrive at targeted tumor site31. Besides, high interstitial fluid 
pressure (IFP) inside the tumor cells serves as a barrier for chemotherapeutic drugs intending to 
penetrate into the tumor cells, thus most of therapeutics only distribute around the peripheral of 
tumor32. Therefore, the ability to monitor and track therapeutic drugs is highly desirable to 
identify premature clearance, locate drug accumulation site and distribution, so as to achieve a 
better drug prognosis and to comprehend treatment failures33. To render real time reporting of 
drug circulation and distribution upon in vivo administration, image-guided drug delivery or 
theranostic systems have been widely explored to incorporate chemotherapeutic drugs with 
different imaging modalities such as PET34, SPECT35, MRI36, and ultrasonic37. MRI is one of the 
most commonly used diagnostic methods thanks to its superior spatial resolution and soft tissue 
contrast. However, most currently available MRI contrast agents are made from metal-chelators 
such as gadolinium (Gd), which are highly toxic in their free ionic forms. It has been reported to 
trigger nephrogenic systemic fibrosis38 and very recently was found to deposit even in the brain of 
patients without severe renal dysfunction39.  
Chemical Exchange Saturation Transfer (CEST) is an emerging MRI contrast 
mechanism, which utilizes special MRI pulse sequence to selectively detect exchangeable protons 
on each probe at their unique chemical shift (frequency offset), translating them into a frequency-
specific molecular imaging agents.40, 41 The exchangeable protons are detected by the attenuation 
of MRI (water) signal caused by the continuous transfer of the saturated (NMR signal being 
nulled) protons from the probes to their surrounding water molecules.  Using the CEST approach, 
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bio-organic molecules42-45 containing exchangeable protons such as –OH, –NH and –NH2 groups 
can be saturated by a specific radiofrequency pulse. For example, a series of X-ray contrast 
agents, Iopamidol,46 Iopromide,47, 48 and Iobitridol49 with –NH proton were shown to exhibit 
CEST MRI signal that enabled in vivo microenvironment pH mapping. More importantly, CEST 
potentially can also be used to detect therapeutic drugs42, 50, drug/gene delivery systems51, 52 and 
the subsequent tumor responses53-55 in a “label-free” manner. One unbeatable advantage to use 
CEST MRI for pursuing image-guided drug delivery is that, with the intrinsically endowed CEST 
contrast, extensive chemical labelling of bioactive molecules can be avoided, namely “natural 
labelling”.  
Herein, we report an FDA-approved anticancer drug, Pemetrexed (Pem), marketed under 
the trade name Alimta,56 has an inherent CEST MRI signal at 5.2 ppm frequency offset from the 
resonance of water. After being covalently linked a short peptide to form an amphiphilic Pem-
peptide conjugate, the self-assembly of nanofibers hydrogel could be spontaneously formed, 
which is not only injectable for intra-tumor treatment but also detectable by CEST MRI. We 
demonstrated that the delivery and distribution of Pem-peptide nanofiber hydrogel can directly 
assessed by CEST MRI in a mouse glioma model. 
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Chapter 3: Materials and Methods 
3.1 Synthesis and molecular characterization 
3.1.1 Materials 
Fmoc amino acids and Fmoc-Glu(OtBu)-Wang resin were purchased from Advanced 
Automated Peptide Protein Technologies (AAPPTEC, Louisville, KY). Pemetrexed (Pem) was 
purchased from AvaChem Scientific (San Antonio, TX). Lauric acid was purchased from Fisher 
Scientific (Pittsburgh, PA). Hydrochloric acid was purchased from EMD Millipore (Billerica, 
MA), and sodium hydroxide was purchased from Fisher Scientific (Fair Lawn, NJ). 
3.1.2 Synthesis of PemFE and C12FE 
The peptide Fmoc-FFEE was synthesized on a Focus XC automated peptide synthesizer 
(AAPPTEC, Louisville, KY) with the scale of 0.25 mmole by utilizing standard Fmoc-solid phase 
synthesis techniques. Fmoc deprotection was followed using 20% 4‐methylpiperidine in DMF 
solution for 15 minutes, repeating once. After Fmoc deprotection, lauric acid was manually 
coupled to N-terminus of NH2-FFEE at the ratio of Lauric acid/HBTU/DIEA 4:4:10 relative to 
the peptide, shaking overnight at room temperature. The coupling of Pem was performed 
manually at N-terminus of NH2-FFEE by adding Pem/HBTU/DIEA at a ratio of 1.2:1.2:3 relative 
to the peptide, shaking overnight at room temperature. In all cases, reactions were monitored by 
the ninhydrin test (Anaspec Inc., Fremont, CA) for free amines. Both C12FE and PemFE were 
cleaved from the Wang resins using the standard cleavage solution of TFA/TIS/H2O (92.5:5:2.5) 
for 2.5 hours. Excessive TFA was removed by air blow, and the remaining peptide solution was 
titrated with cold diethyl ether to precipitate crude peptide. The precipitated crude peptide and 
diethyl ether were phase-separated using centrifugation technique (5900 rpm for 3 minute) and 
diethyl ether solution was discarded. To remove as much TFA as possible, the washing step was 
carried out by adding 40 mL of diethyl ether to crude peptide, vortexed, sonicated and 
centrifuged. This procedure was repeated 3 times. All centrifuge tubes were tightly sealed with 
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parafilm to minimize evaporation of diethyl ether during high-speed centrifugation. After 
centrifuge, the precipitate was dried under vacuum overnight.  
3.1.3 Purification 
The peptides were purified by preparative RP-HPLC with a Varian Polymeric Column 
(PLRP-S, 100 Å, 10 µm, 150 × 25 mm) at 25 ℃  on a Varian ProStar Model 325 preparative 
HPLC (Agilent Technologies, Santa Clara, CA) equipped with a fraction collector.  
C12FE peptide was dissolved in 20 ml of 0.1% v/v NH4OH. A water/acetonitrile 
gradient 5%-100% was ran for 30 minutes containing 0.1% v/v NH4OH was used as eluent at a 
flow rate of 20 mL/min. 
The crude PemFE peptide was initially dissolved in 20 ml of 0.1% v/v NH4OH, then 
diluting with 20 ml of 0.1% v/v TFA. A water/acetonitrile gradient 5%-50% was ran for 30 
minutes containing 0.1% v/v TFA was used as eluent at a flow rate of 20 mL/min. 
The absorbance peak was monitored at 220 nm. Peptide identity was confirmed by ESI-
MS (LDQ Deca ion-trap mass spectrometer, Thermo Finnigan, San Jose, CA). Collected fractions 
containing desired products were lyophilized (FreeZone -105 °C 4.5 L freeze dryer, Labconco, 
Kansas City, MO) and stored at -30 ℃ . 
3.1.4 Electrospray Ionization-Mass Spectra (ESI-MS) 
ESI mass spectra were acquired using a Finnigan LCQ Deca ion-trap mass spectrometer 
equipped with an electrospray ionization source (Thermo Finnigan, San Jose, CA). Samples were 
dissolved in water with 5% of acetonitrle containing 0.1% v/v NH4OH and introduced into the 
instrument at a rate of 10 µL/min using a syringe pump via a silica capillary line. The heated 
capillary temperature was 250 ℃  and the spray voltage was 5kV.  
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Figure 6. ESI-MS of a) PemFE and b) C12FE molecules. The exact mass of PemFE and C12FE 
are 979.37 and 752.40, respectively. 
3.1.5 Analytical HPLC Characterization 
Analytical RP-HPLC was performed using a Varian polymeric column (PLRP-S, 100 Å, 
10 µm, 150 × 4.6 mm) with 20 µL injection volume. A water/acetonitrile gradient 5%-100% was 
ran for 30 minutes containing 0.1% v/v NH4OH at a flow rate of 1 mL/min.  
 
Figure 7. Analytical RP-HPLC of a) PemFE and b) C12FE. PemFE isomer resulted in a shoulder 
peak in plot a). 
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3.1.6 PemFE Isomer 
 
Figure 8. Chemical structure of PemFE isomer. 
3.1.7 Drug loading for PemFE 
Pem mass = 427.4 g/mol – 17 g/mol (-OH) = 410.4 g/mol 
PemFE mass = 979.3 g/mol 
PemFE drug loading = 410.4/979.3 × 100% = 41.9%  
3.2 Self-assembly characterization 
3.2.1 Transmission electron microscopy (TEM) imaging protocol 
4 mM solutions of C12FE and PemFE in 1xDPBS were prepared by directly dissolving 
lyophilized powders, and allowed to age overnight. A sample for imaging was prepared by 
depositing 5 µL of the solution onto a carbon-coated copper grid (Electron Microscopy Services, 
Hatfield, PA, USA), wicking away the excess solution with a small piece of filter paper. Next, 5 
µL of a 2 wt % aqueous uranyl acetate solution was deposited and the excess solution was 
carefully removed as above to leave a very thin layer. The sample grid was then allowed to dry at 
room temperature prior to imaging. Bright-field TEM imaging was performed on a FEI Tecnai 12 
TWIN Transmission Electron Microscope operated at an acceleration voltage of 100 kV. TEM 
images were recorded by a 16 bit 2K × 2K FEI Eagle bottom mount camera.  
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3.2.2 Cryogenic TEM protocol 
To visualize nanostructures in its solution-state through a vitrified thin-film, cryo-TEM 
imaging was performed on the FEI Tecnai 12 TWIN Transmission Electron Microscope, 
operating at 80 kV. C12FE and PemFE samples were prepared at 4mM in PBS, the same 
concentration as conventional TEM. Prior to sample preparation, all TEM grids were treated with 
plasma air to make the lacey carbon film hydrophilic. The Vitrobot with a controlled humidity 
chamber (FEI) was used to generate a thin film of sample on grid. The lacey carbon grid 
(Electron Microscopy Services, Hatfield, PA) was blotted and plunged into liquid ethane pre-
cooled by liquid nitrogen. All vitrified samples were transferred to a cryo-holder filled with liquid 
nitrogen to prevent sublimation of vitreous water. The images were recorded by a 16 bit 2K × 2K 
FEI Eagle bottom mount camera. 
3.3 In vitro MRI CEST measurement 
In vitro CEST MRI images were acquired on a 9.4T Bruker Avance system equipped 
with a 15 mm sawtooth RF coil. A modified RARE sequence (TR=6.0 sec, effective TE=43.2 ms, 
RARE factor=16, slice thickness=1 mm, FOV=14x14 mm, matrix size=128x64, resolution= 
0.11x0.22 mm2, and NA=2) including a magnetization transfer (MT) module (one CW pulse, B 
=3.6 µT (150 Hz), 3sec) was used to acquire CEST weighted images from -7 ppm to 7 ppm 
(step=0.2 ppm) around the water resonance (0 ppm)57. The absolute water resonant frequency 
shift was measured using the WAter Saturation Shift Reference (WASSR)58 method modified 
with Lorentzian analysis. The same parameters as in CEST imaging were used except TR=1.5 sec, 
tsat=500 ms, B1=0.5 µT (21.3 Hz) and the saturation frequency swept from -1ppm to 1ppm (step= 
0.1 ppm). 
Data processing was performed using custom-written scripts in MATLAB (Mathworks, 
Waltham, MA). CEST spectra were calculated from the mean of an ROI placed over each sample 
after B0 correcting the contrast on a per voxel basis. The CEST signal was quantified using 
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MTRasym at particular offsets of interest (i.e. Δω= +2.2 ppm) using the definition: MTRasym = (S-Δω 
– S+Δω)/ S0, where and S[-Δω, +Δω] is the water signal intensity in the presence of saturation pulse at 
offsets ±Δω, and S0 is the water signal intensity in the absence of saturation pulses.  
C12FE, PemFE and Pem samples were prepared at 10mM in 1xDPBS solution. A pH 
series ranging from 6.0 to 8.5 with an increment of 0.5 was studied, and sodium hydroxide or 
hydrochloric acid solution was used to achieve expected pH. 1 M solution of sodium hydroxide 
was prepared by dissolving solid sodium hydroxide in deionized water, while 11 M hydrochloric 
acid was diluted with water to 1 M hydrochloric acid. Samples were triplicated at each pH. After 
pH adjustment, samples were transferred to capillary tubes and then arranged on a sample holder.  
The exchange rates of exchangeable protons of 10 mM Pem, PemFE and C12FE at 
different pHs were measured using the modified QUantifying Exchange using Saturation Time 
(QUEST) method59. In brief, the CEST contrast at 5.2 ppm for each sample was measured with 
saturation delays of 0.5, 1, 1.5, 2, 3 and 6 sec, using a saturation field strength of 4.7 µT (200Hz) 
and the repetition time (TR) set to 10 sec, using the RARE imaging sequence described 
previously. The calculated MTRasym values were then fit using numerical solutions to the Bloch 
equations with exchange rate (kex). The water T1w and T2w were experimentally determined 
using a saturation recovery spin echo method and CPMG multi-echo spin echo sequence 
respectively. The fixed model parameters were water solute R1s= 0.71 Hz and solute R2s= 39 Hz.   
3.4 PemFE and C12FE hydrogels 
PemFE and C12FE hydrogel were prepared in the final concentration of 30 mM, 
dissolved in 1xDPBS solution and sonicated for 2 minutes to aid in dissolving lyphophilized 
powder form of respective molecules. Samples were aged overnight and hydrogel photos were 
taken by inverting both sample vials. 
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3.5 In vivo MRI study 
All experiments conducted with mice were performed in accordance with protocols 
approved by the Johns Hopkins University Institutional Animal Care and Use Committee 
(IACUC). In vivo images were acquired on an 11.7 T Bruker Biospec horizontal bore scanner 
(Bruker Biosciences, Billerica, MA) equipped with a 23 mm Circular Polarized MRI transceiver 
volume coil. The same imaging scheme described above with addition of a fat suppression pulse 
(3.4 ms hermite pulse, offset=-3.5 ppm).  The acquisition parameters were:  TR=5.0 sec, effective 
TE= 6 ms, RARE factor=10, tsat=3 sec, B1=3.6 µT (150 Hz), slice thickness=1 mm, acquisition 
matrix size=128x64, FOV=20x20 mm, and NA=2. Due to the B0 field inhomogeneity, we 
incremented the saturation offset ± 1 ppm (0.1 ppm steps) with respect to water for B0 mapping.  
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Chapter 4: Results and Discussion 
4.1 Molecular Design 
Pemetrexed (Pem) is a chemotherapeutic drug composed of aromatic amines and 
secondary amines in its nature structure (Pem in blue, Figure 9a). These exchanging protons 
posses a chemical shift (5.2 + 4.7 ppm, by NMR convention) distinct from water, in which can be 
selectively saturated and transferred to bulk water through chemical exchange, resulting in a 
decrease of water signal (Figure 9b). Subsequently, the decrease in water signal “before” and 
“after” the application of saturation RF pulses is computed as the magnetization transfer ratio 
(MTRasym), providing a way to quantify the CEST effect corresponded to the amount of Pem. 
Thus, Pem can be used as a CEST MRI contrast agent. Because Pem (Figure 9a) is a 
hydrophobic anticancer drug, based on our previous studies60-63, it has the potential to self-
assemble into nanofibers under physiological condition (Figure 9c). To construct the Pem-peptide 
nanostructure, we chemically conjugated it to a hydrophilic peptide, two glutamic acids (EE), to 
create an amphiphilic prodrug molecule that can self-assemble into nanostructure64, 65. Glutamic 
acid residues, which carry negative charge on its side chain, are deliberately included in our 
design to minimize the ionic-induced cytotoxic effect commonly reported in positively charged 
nanoparticles.66 To promote the self-assembly of PemFE into nanofibers hydrogel, two 
phenylalanine (FF) was incorporated into the peptide sequence. The phenylalanine benzyl side 
chain that composed of π-segment, was shown to direct the self-assembly of amphiphilic peptide 
into 1-dimensional nanostructures, such as nanotubes or nanofibers through π-π stacking67, 68. 
With this drug-peptide conjugate design, the Pem drug loading can be precisely fixed at 42 wt% 
which is defined by the mass of Pem divided by the total molecular weight of PemFE conjugate 
(as discussed in Material and Method 3.1.7). Our previous work64, 65, 69 also demonstrated that this 
concept can be employed for other anticancer drugs to achieve higher drug loading compared to 
tradition drug encapsulation method (<5 wt%) and drug-polymer conjugate approach (~10 wt%)70. 
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Due to the dual carboxylic acid functional sites on the Pem, our designed molecule PemFE 
possibly co-exist with its structural isomer as denoted by asterisk (*) in Figure 9a. Since the 
aromatic amine site is preserved in both PemFE and its structural isomer, we presumed that their 
CEST properties are unaffected. As a control molecule, we designed the C12FE molecule (Figure 
9a), by replacing Pem drug with a C12-hydrocarbon tail as the hydrophobic entity to facilitate the 
self-assembly process of nanofiber formation, providing the physical feature similar to PemFE.   
 
Figure 9. Illustration of Molecular Design. a) Chemical structure of molecule PemFE and 
C12FE, where the CEST MRI signal of PemFE originates from aromatic amine exchanging 
proton on Pem (blue). A possible PemFE structural isomer conjugation site is indicated by 
asterisk (*). b) CEST contrast is measured by a decrease in water signal after the selectively 
saturated 5.2 ppm exchanging proton is being transferred to bulk water. c) Illustration of PemFE 
monomers self-assembled into nanofiber and hydrogel-state. 
4.2 Molecular self-assembly and characterization 
The self-assembly of PemFE and C12FE were initiated by dissolving the lyophilized 
molecules into Dulbecco’s phosphate-buffered saline (1xDPBS). The self-assembled 
nanostructures were observed under vitrified liquid using cryo-Transmission Electron 
Microscopy (TEM) without staining and regular TEM with negative staining. In Figure 10b, e, 
cryo-TEM micrographs showed that both PemFE and C12FE molecules self-assembled into 
cylindrical-shaped nanofibers in physiological buffer (1xDPBS) at 4 mM concentration (per 
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conjugate), after aged for 1 day at room temperature. According to the diameter analysis of 
PemFE and C12FE nanofibers obtained from TEM images (Figure 10a, d), their respective 
diameters are 9.1 ± 1.4 nm and 8.5 ± 0.9 nm. The diameters of these nanofibers which correspond 
to approximately twice of the expected molecular length (~3.9 nm and ~3.2 nm, respectively, 
estimated from ChemDraw), indicating a core-shell packing model assembled into a cylindrical 
geometry. In addition, the lengths of these nanofibers are in the micrometer range, which form a 
dense nano-fabric network at high concentration. Consequently, at macroscopic level, PemFE 
and C12FE exist as self-supporting hydrogels at 30 mM in 1xPBS solution as shown in Figure 
10c and 10f, respectively. This class of self-assembling hydrogel has emerged as a versatile 
strategy for slow release of bioactive molecules, an unique alternative in drug-delivery systems.71-
73 Due to the non-covalent interactions among nanofibers, this type of hydrogel is also injectable 
under proper shear stress and would recover back to its gel state after injection, which is highly 
desirable for in situ applications74. 
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Figure 10. Demonstration of nanostructure formed by PemFE and C12FE. a) b) Cryo-TEM 
micrograph and regular TEM micrograph of PemFE, 4mM. c) Digital photographs of PemFE in 
30 mM dissolved in 1xDPBS solution and aged overnight: inversion demonstrates self-supporting 
hydrogel formed by PemFE nanofibers. d) e) Cryo-TEM micrograph and regular TEM 
micrograph of C12FE, 10mM. f) Digital photographs of PemFE in 30 mM dissolved in 1xDPBS 
solution and aged overnight: inversion demonstrates self-supporting hydrogel formed by C12FE 
nanofibers. 
4.3 In vitro CEST MRI Measurement 
MRI contrast measurements revealed that Pem-containing molecules generate a strong 
CEST signal at ~5.2 ppm, while the control molecule C12FE showed negligible CEST signal at 
pH 7.4. We first prepared PemFE, C12FE and Pem at 10 mM concentration (in PBS, pH 7.4, 
and 37 oC) and measured their CEST properties on a 9.4 T vertical bore Bruker MRI scanner 
using a previously reported procedure75. The CEST effect was displayed as Z-spectra (Figure 
11a) and further quantified using MTRasym(Figure 11b), as defined by MTRasym=(S-Δω – S+Δω)/ S0, 
where S-Δω and S+Δω are the MRI signal intensities after saturation at -Δω and +Δω frequency 
offsets from the water proton frequency (set at 0 ppm); So is the intensity in the absence of a 
saturation pulse. Both Z-spectra and MTRasym plots clearly showed a strong CEST signal at ~5.2 
ppm. At this frequency offset, as shown in the color-coded CEST parametric map (Figure 11e), a 
conspicuously different CEST signal can be detected between PemFE and the control molecule 
C12FE. We speculate this CEST signal arises from the aromatic primary amine’s exchanging 
proton on the Pem molecules (~10.15 ppm using 1H NMR spectrometry76). It should be noted 
that, due to the fast exchange rate, the CEST peak at 5.2 ppm is broad and the exact offset to 
obtain the ‘peak’ CEST effect was observed to be slightly varied (i.e., ranging from 5.0 to 5.4 
ppm) for samples at different pH or when different saturation power were used (Figure 11c, d). 
As pH increased from 6.0 to 8.0, the MTRasym value of CEST peak at 5.2 ppm increased as well.  
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Figure 11. Basic CEST characterization. a) CEST spectra and b) MTRasym plot of PemFE 
(solid), Pem (dashed), and C12FE (dotted) showed CEST peaks at 5.2 ppm. The MTRasym plots 
of PemFE c) at different pH (using a B1=3.6µT), and d) acquired using different B1 values 
(pH=7.4). The vertical line shows the offset at 5.2 ppm. e) Color coded CEST contrast map of 
Pem, PemFE, and C12FE with respect to 5.2 ppm offset from water. 
At the same concentration, PemFE showed slightly lower CEST signal compared to free 
Pem. We speculate that the self-assembly of PemFE into core-shell structure, which positioned 
Pem in the center of nanofiber structure is limiting the accessibility of Pem-exchanging proton to 
the surrounding water protons, therefore exhibited a slightly lower CEST signal than free Pem 
(Figure 11a, b). The suppression or acceleration of proton exchange rates, as a result of distinct 
water exposure of exchanging protons has been reported in other literature as well, to probe the 
differences in protein conformational structures77, 78. Nevertheless, PemFE is still CEST-
detectable and its CEST signal at 5.2 ppm offset is markedly higher compared to the control 




Figure 12. Comparing CEST properties of PemFE, Pem and C12FE, each at 10 mM in 1xDPBS 
solution at 37 oC. a) MTRasym at 5.2 ppm of all designed molecules at pH 7.4, measured at 
different saturation field strength; b) PemFE MTRasym at 5.2 ppm measured with respect to pre-
saturation time (Tsat) at pH 6, 7, and 8. c) Pem MTRasym at 5.2 ppm measured with respect to 
pre-saturation time (Tsat) at pH 6, 7, and 8. d) C12FE MTRasym at 5.2 ppm measured with 
respect to pre-saturation time (Tsat) at pH 6, 7, and 8. e) MTRasym at 5.2 ppm as a function of 
pH using B1 = 3.6 µT. QUEST method was used to fit data and obtain kex values; f) pH 
dependence of proton exchange rate (kex) as a function of pH using B1 = 3.6 µT.  
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The apparent CEST effect is strongly dependent on the saturation parameters. Figure 12a 
shows that both Pem and PemFE (10 mM, pH 7.4) exhibited a linear increase with respect to 
higher saturation field strength (B1). Considering higher B1 also can cause a too strong direct 
water saturation effect and severe unwanted Magnetization Transfer effect for the in vivo cases, 
we chose B1 = 3.6 µT for subsequent in vivo studies. Figure 12b showed the example of the 
QUEST analysis of saturation time (Tsat)-dependent CEST effect of PemFE at pH 6 (dotted line), 
pH 7 (solid line), and pH 8 (dashed line). The same analysis was performed for Pem and C12FE 
and results are shown in Figure 12c, d. As expected, MTRasym at 5.2ppm increased with 
increasing Tsat for Pem-containing molecules. However, for Tsat longer than 3 seconds, CEST 
effect did not increase significantly. Therefore, a Tsat of 3 seconds was considered as the optimal 
value and was used in the subsequent studies.  
 
When studied in the pH range from pH 6.0 to pH 8.5, Pem, PemFE and C12FE 
exhibited different pH-dependence CEST contrast as shown in Figure 12e. Both free Pem and 
PemFE had a biphasic response, i.e., first increased and then decreased, to the pH increase. The 
maximal CEST contrasts were observed at pH 7.4 and pH 7.0 for Pem and PemFE respectively; 
C12FE clearly showed a continuously decrease of CEST contrast when pH increased although 
the maximal CEST contrast was only 0.01± 0.001. The high correlation of Pem and PemFE 
CEST contrast to pH condition indicated that the exchange rate (ksw) of Pem amine proton 
changed dramatically at different pH. To estimate the exchange rate (kex), we measured the 
MTRasym values at 5.2 ppm with saturation time (Tsat) ranging from 0.5 to 6 seconds and analyzed 
the data using the previously reported QUEST (QUantifying Exchange rates using Saturation 
Time) method79. The pH dependence of proton exchange rate (kex) of each compound is shown in 
Figure 12f. The estimated Pem proton exchange rate is in the order of 102-103 s-1, which is 
comparable to kex reported in other literature.45, 49 Both Pem and PemFE clearly exhibited a 
biphasic kex function with respect to pH (Figure 12f). The initial pH-dependent increase is 
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attributed to the gradual increase of exchange rate when pH increases like all the base-catalyzed 
proton exchanges77. However, the second phase in which kex drops when pH further increases is 
unexpected. We speculate it is because the further increase of pH indeed makes the kex too fast 
that has exceeded the slow-to-moderate exchange rate region (i.e., kex > Δω), which instead 
compromises the CEST signal and lowers the apparent CEST contrast.  
4.4 In vivo CEST MRI Time-Point Study and Spatial Comparison 
In vivo study demonstrated that the injected PemFE hydrogel in mouse glioma tumors 
could be detected using CEST MRI for up to 4 days post-implantation. To assess the potential use 
of PemFE hydrogel in vivo, a GL261 orthotopic brain tumor model was used. In brief, C57BL6 
mice (female, 5-6 weeks, n=5) were stereotactically injected with 2x104 GL261 cells in the right 
hemisphere of mouse brain. Twenty-five days after the inoculation of tumor cells, hydrogel was 
injected into the tumors using the same stereotactic settings and in vivo MRI was performed 
before and after 2 and 96 hours post-injection on a Biospec11.7 T MRI scanner equipped with a 
23 mm mouse brain volume coil.  CEST MRI acquisition and data processed were performed as 
previously reported (B1= 3.6 µT and Tsat= 3 sec)75. As shown in Figure 13a, a localized but not 
uniform PemFE hydrogel distribution in the tumor could be appreciated by comparing the CEST 
MRI signal acquired at 2 hours after the injection and that before injection. After 4 days, PemFE 
hydrogel was still CEST detectable but appeared as a more uniform distribution in a larger area, 
indicating a slow gradient-driven diffusion to nearby tumor cells. This study clearly demonstrated 
that PemFE hydrogel is a promising slow-release implantable drug delivery system with its 
location and distribution directly monitored by CEST MRI without any imaging agents.  
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Figure 13. MRI detection of PemFE, pemetrexed (Alimta) conjugated nanofibers hydrogel that 
was stereotactically injected in brain tumors (day 25 after tumor implantation). a) On the top, 
MRI images showing GL261 brain tumor at different time points (with respect to the time of 
injection of nanofiber hydrogel); On the bottom, CEST maps at 5.2 ppm of the mouse brain 
before, 2 hours and 4 days after the PemFE injection. b) Illustration of choosing ROIs on 
overlaid CEST images at 2 hours after the PemFE hydrogel injection to represent tumor regions 
of ROI1 - the PemFE injection site with increased CEST contrast and ROI2 - its surrounding 
region, without CEST contrast. c) The quantification of CEST contrast showing a significant 
higher MTRasym values for PemFE injection site than surrounding tumor (P> 0.05, two-tailed, 
paired Student t-test, n=5).  
To further evaluate the imaging capability of PemFE hydrogel, we quantitatively 
analyzed the CEST MRI signal at the injection site compared to its surrounding/background. 
Figure 13b showed an overlay image of the CEST parametric map (threshold by MTRasym > -0.01) 
at 2 hours post-injection of PemFE hydrogel and a T2w anatomical image. We chose two ROIs 
(region of interest - ROI) in the tumor with ROI1 representing the region has a strong signal and 
ROI2 representing the region that has low CEST MRI contrast. Then we repeated the same 
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analysis on four more mice. As shown in Figure 13c, the mean CEST contrast between the ROI1 
(injection site in the tumor) and ROI2 (surrounding region in the corresponding tumor) was 0.024 
in MTRasym, which is statistical significant (P=0.045, two-tailed, paired Student t-test).  
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Chapter 5: Conclusions 
In summary, we successfully developed a novel CEST MRI detectable drug-peptide 
nanofiber hydrogel system. With the inherent CEST MRI signal carried by Pem-containing 
molecules at 5.2 ppm, the location, distribution and drug release of the injected PemFE hydrogel 
could be easily monitored by CEST MRI in a label-free manner. The conjugation of self-
assembling peptide to Pem drug entails the formation of PemFE nanofibers hydrogel, exhibits 
slow-release characteristic of Pem over time. This new injectable and CEST MRI-detectable 
nanofiber hydrogel will be ideal for image-guided drug delivery of anticancer drug Pemetrexed 
(Pem) because it solely composed of the drug (Pem) and peptide (FFEE) and the MRI 
detectability stems from the inherent CEST signal of Pem. The proof-of-concept in using drug-
peptide nanofiber for in vivo CEST MRI detection was demonstrated in an orthotopic brain tumor 
mouse model. While further therapeutic evaluations are anticipated, the current study 
demonstrated a strategy for constructing metal-free and highly translatable MRI guided drug-
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